AI Analysis
Log in to generate an AI summary for this stock.
Log in to generate a MOAT report for this stock.
Log in to generate an earnings report for this stock.
Log in to generate an operating leverage report for this stock.
Log in to generate a management report for this stock.
Log in to generate a valuation report for this stock.
Perimeter Medical Imaging AI, Inc.
Video analysis: PYNKF
All videosNo video analysis for this stock yet. Request one from our team.
News: PYNKF
Perimeter Medical Imaging AI, Inc. (PINK:CA) Q2 2026 Earnings Call Transcript
Perimeter Medical Imaging AI, Inc. (PINK:CA) Q2 2026 Earnings Call Transcript
Perimeter Announces Preliminary Second Quarter 2026 Financial Results
Results characterized by continued strong commercial momentum and improved operating performance Conference call/webcast today at 5:00 pm ET TORONTO and DALLAS, Aug. 20, 2026 /PRNewswire/ -- Perimeter Medical Imaging AI, Inc. (TSXV: PINK) (OTCQX: PYNKF) ("Perimeter" or the "Company"), a commercial-stage medical technology company, today reported preliminary financial results for its second quarter ended June 30, 2026, and provided a corporate update. Unless specified otherwise, all amounts in this press release are expressed in U.S. dollars and are presented in accordance with International Financial Reporting Standards as issued by the International Accounting Standards Board.
Perimeter Schedules Second Quarter 2026 Financial Results Conference Call for August 20th
TORONTO and DALLAS, Aug. 13, 2026 /PRNewswire/ -- Perimeter Medical Imaging AI, Inc. (TSXV: PINK) (OTCQX: PYNKF) ("Perimeter" or the "Company"), a commercial-stage medical technology company, announced it will report its second quarter 2026 financial and operating results after market close on Thursday, August 20, 2026. Following the announcement, Perimeter management will host a webcast and conference call to discuss the results and provide a corporate update.
Intermountain Health Brings Perimeter's Claire™ to the Operating Room, a Landmark in Breast Cancer Surgery Using AI
Health system is first to commercially deploy Claire, the only FDA-approved, AI-enabled imaging device for margin assessment during breast-conserving surgery in the U.S. Claire is designed to enhance surgeons' ability to detect difficult-to-see cancer - far beyond what's visible to the naked eye - in real-time in the OR TORONTO and DALLAS, Aug. 13, 2026 /PRNewswire/ -- Perimeter Medical Imaging AI, Inc. ("Perimeter" or the "Company") (TSXV: PINK) (OTCQX: PYNKF), a commercial-stage medical technology company, today announced that Intermountain Health, the largest nonprofit health system in the Mountain West region, has become the first health system in the U.S. to commercially deploy Perimeter's Claire OCT System™, the only FDA-approved imaging device that uses AI during breast cancer surgery to help surgeons see microscopic tissue structures - where cancer can be difficult to detect - in real-time, for margin assessment. The stakes are significant: about one in five patients needs follow-up breast cancer surgeries because cancer wasn't detected in the operating room the first time.1 "Every breast surgeon wants to give their patient the best possible chance of completing treatment in a single surgery, but microscopic cancer can be difficult to identify in the operating room," said Dr. Teresa Reading, a breast surgeon at Intermountain Health LDS Hospital in Salt Lake City.
Perimeter Medical Imaging AI to Participate in the Planet MicroCap Showcase in Las Vegas
TORONTO and DALLAS, June 15, 2026 /PRNewswire/ - Perimeter Medical Imaging AI, Inc. (TSXV: PINK) (OTCQX: PYNKF) ("Perimeter" or the "Company"), a commercial-stage medical technology company, is pleased to announce that its CEO, Adrian Mendes, will present a Company update regarding current commercial strategy and discuss upcoming milestones at the Planet MicroCap Showcase on Wednesday, June 17, 2026 at 12:00 p.m. PDT (3:00 p.m.
Similar companies
-
Positron Corporation
POSC
·
Other OTC
Compare
-
ImpediMed Limited
IPDQF
·
Other OTC
Compare
-
Guided Therapeutics, Inc.
GTHP
·
Other OTC
Compare
-
Isracann Biosciences Inc.
ISCNF
·
Other OTC
Compare
-
ALR Technologies Inc.
ALRTF
·
Other OTC
Compare
-
Institute of Biomedical Research Corp.
MRES
·
Other OTC
Compare